News About 手机买球 Members

FlowMetric Life Sciences Receives CLIA High Complexity Laboratory Certification

FlowMetric Life Sciences Inc. announced today (June 25) that the state of Pennsylvania has certified the FlowMetric Diagnostics laboratory as a High Complexity laboratory under the Clinical Laboratory Improvement Amendments (CLIA) of 1988. Read more.

 

FDA Grants Breakthrough Device Designation for Seravue® to Support Earlier Diagnosis of Liver Cancer by Simple Blood Test

Seravue® is intended for use as an aid in the diagnosis of Hepatocellular Carcinoma (HCC), including early stage HCC, in patients with an elevated risk of developing HCC, in conjunction with ultrasound imaging or alone in cases where ultrasound is deemed inappropriate. Read more.

 

Arbutus Announces Single-Dose Week 12 Data in Chronis Hepatitis B Subjects with 60 mg AB-729 Demonstrating a Significant and Continuous Reduction in HBsAg

Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company focused on developing a cure for people with chronic hepatitis B virus (HBV) infection, today (May 18) reports positive follow-up data from a Phase 1a/1b clinical trial (AB-729-001) in chronic HBV subjects on nucleos(t)ide therapy who received a single subcutaneous injection of 60 mg of AB-729, a proprietary GalNAc delivered RNAi compound. Read more.